Pittenger & Anderson Inc Amgen Inc Transaction History

Pittenger & Anderson Inc

$2.5 Billion
Q3 2024

A detailed history of Pittenger & Anderson Inc transactions in Amgen Inc stock. As of the latest transaction made, Pittenger & Anderson Inc holds 2,460 shares of AMGN stock, worth $688,972. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,460

Previous 2,460 -0.0%

Holding current value

$688,972

Previous $768,000 3.13%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$218.65 - $271.46 $65,595 - $81,438	-300 Reduced 10.87%	2,460 $661,000
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $3,229 - $3,594	-14 Reduced 0.5%	2,760 $672,000
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $340,087 - $376,226	-1,551 Reduced 35.86%	2,774 $671,000
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $6.76 Million - $7.73 Million	-33,982 Reduced 88.71%	4,325 $973,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $119,720 - $140,266	-564 Reduced 1.45%	38,307 $8.15 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $65,635 - $72,818	281 Added 0.73%	38,871 $9.48 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $588,505 - $685,807	2,652 Added 7.38%	38,590 $9.6 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $88,932 - $105,902	411 Added 1.16%	35,938 $8.26 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $127,414 - $141,695	543 Added 1.55%	35,527 $9.03 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $72,596 - $89,085	367 Added 1.06%	34,984 $8.25 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $65,970 - $87,495	362 Added 1.06%	34,617 $7.02 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $22,137 - $28,454	-117 Reduced 0.34%	34,255 $8.26 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $36,040 - $43,184	-207 Reduced 0.6%	34,372 $6.65 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $395,079 - $463,121	2,370 Added 7.36%	34,579 $6.37 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $118,831 - $133,949	657 Added 2.08%	32,209 $6.12 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $109,180 - $127,449	612 Added 1.98%	31,552 $6.14 Million
Q3 2018 Oct 12, 2018	BUY	$185.29 - $208.89 $166,761 - $188,001	900 Added 3.0%	30,940 $6.41 Million
Q2 2018 Aug 15, 2018	BUY	$166.05 - $186.51 $432,560 - $485,858	2,605 Added 9.5%	30,040 $5.55 Million
Q1 2018 May 08, 2018	BUY	$169.43 - $198.0 $686,530 - $802,296	4,052 Added 17.33%	27,435 $4.68 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $21,098 - $23,573	125 Added 0.54%	23,383 $4.07 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $39,313 - $44,885	-235 Reduced 1.0%	23,258 $4.34 Million
Q2 2017 Aug 10, 2017	BUY	N/A	23,493	23,493 $4.05 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.

Account

Pittenger & Anderson Inc Amgen Inc Transaction History